PDGFRA and neoplasm: Although KIT and PDGFRA mutations are likely of key importance in the molecular pathogenesis of GISTs, identical single KIT or PDGFRA mutations may be associated with widely different tumour mitotic counts and GIST patient survival outcome 2.